May 27, 2026
Pirouette Pharma was proud to participate in the New Hampshire MedTech Lightning Showcase (NHLS), where Chief of Staff Erin Beauregard and Vice President of Quality Emily Deane represented the company among a select group of innovators advancing the region’s life sciences ecosystem.
Hosted in Nashua on May 27, 2026, the invite-only event brought together emerging medtech and biotech companies, industry leaders, investors, and policy experts for an evening of rapid-fire presentations, panel discussions, and networking. The showcase is designed to highlight the strength and growing momentum of New Hampshire’s medical device and life sciences community through concise, two-minute pitches and high-impact engagement across the ecosystem.
During the lightning pitch session, Erin Beauregard presented Pirouette Pharma’s work and growing presence in New Hampshire. Their remarks focused on the company’s commitment to advancing innovative drug delivery solutions while building operational and development capabilities within the state’s rapidly expanding life sciences cluster.
New Hampshire has become an increasingly important hub for medtech innovation, supported by advanced manufacturing capabilities, a skilled workforce, and a collaborative network of companies and institutions. Pirouette’s participation in the showcase reflects both its alignment with this ecosystem and its commitment to contributing to the state’s continued growth as a center for healthcare innovation.


Beyond the formal presentations, the event provided a valuable opportunity to connect with fellow founders, technical experts, and industry leaders. The format combining networking, expert panels on market dynamics and regulatory trends, and a behind-the-scenes look at leading manufacturing capabilities, enabled meaningful dialogue across the medtech community.
For Pirouette, these conversations are instrumental in refining strategy, identifying potential collaborators, and staying at the forefront of industry trends. Engaging with peers and thought leaders helps inform the company’s approach as it advances toward key milestones.
Events like the NH MedTech Lightning Showcase play a critical role in strengthening New Hampshire’s life sciences ecosystem by increasing visibility, fostering collaboration, and accelerating innovation. By bringing together a curated group of companies and stakeholders, the showcase underscores the collective momentum of the region and the importance of partnership in driving progress.
Pirouette Pharma is proud to be part of this growing community and remains committed to supporting innovation in New Hampshire while advancing its mission to place healthcare in the hands of the patient.
